Clinical Trial Update: Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).

View source ↗

Summary

Pfizer is conducting a Korean post-marketing surveillance study of ELREXFIO (elranatamab) in adults with multiple myeloma to monitor safety in real-world use; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ELREXFIO (ELRANATAMAB-BCMM)

Snippet

Sponsor: Pfizer | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING